Seroprevalence of cytomegalovirus infection in the United States, 1988-1994 - PubMed (original) (raw)
. 2006 Nov 1;43(9):1143-51.
doi: 10.1086/508173. Epub 2006 Oct 2.
Affiliations
- PMID: 17029132
- DOI: 10.1086/508173
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994
Stephanie A S Staras et al. Clin Infect Dis. 2006.
Abstract
Background: Cytomegalovirus (CMV) is a leading cause of congenital illness and disability, including hearing loss and mental retardation. However, there are no nationwide estimates of CMV seroprevalence among pregnant women or the overall population of the United States.
Methods: To determine CMV prevalence in a representative sample of the US population, we tested serum samples for CMV-specific immunoglobulin G from participants aged > or =6 years (n=21,639) in the third National Health and Nutrition Examination Survey (1988-1994).
Results: The prevalence of CMV infection was 58.9% in individuals > or =6 years old. CMV seroprevalence increased gradually with age, from 36.3% in 6-11-year-olds to 90.8% in those aged > or =80 years. CMV seroprevalence differed by race and/or ethnicity as follows: 51.2% in non-Hispanic white persons, 75.8% in non-Hispanic black persons, and 81.7% in Mexican Americans. Racial and/or ethnic differences in CMV seroprevalence persisted when controlling for household income level, education, marital status, area of residence, census region, family size, country of birth, and type of medical insurance. Among women, racial and/or ethnic differences were especially significant; between ages 10-14 years and 20-24 years, seroprevalence increased 38% for non-Hispanic black persons, 7% for non-Hispanic white persons, and <1% for Mexican Americans.
Conclusions: On the basis of these results, we estimate that each year in the United States approximately 340,000 non-Hispanic white persons, 130,000 non-Hispanic black persons, and 50,000 Mexican American women of childbearing age experience a primary CMV infection. Given the number of women at risk and the significance of congenital disease, development of programs for the prevention of CMV infection, such as vaccination or education, is of considerable public health importance.
Comment in
- Cytomegalovirus infection: back to the future or no more elephants?
Demmler GJ. Demmler GJ. Clin Infect Dis. 2006 Nov 1;43(9):1152-3. doi: 10.1086/508204. Epub 2006 Oct 2. Clin Infect Dis. 2006. PMID: 17029133 No abstract available.
Similar articles
- Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994.
Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE Jr, Cannon MJ. Staras SA, et al. Sex Transm Dis. 2008 May;35(5):472-9. doi: 10.1097/OLQ.0b013e3181644b70. Sex Transm Dis. 2008. PMID: 18354346 - Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States.
Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE Jr, Cannon MJ. Staras SA, et al. J Clin Virol. 2008 Nov;43(3):266-71. doi: 10.1016/j.jcv.2008.07.012. Epub 2008 Sep 7. J Clin Virol. 2008. PMID: 18778968 - [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S, Colak D, Günseren F, Senol Y, Colak T, Aktekin MR, Gültekin M. Ataman S, et al. Mikrobiyol Bul. 2007 Oct;41(4):545-55. Mikrobiyol Bul. 2007. PMID: 18173073 Turkish. - Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.
Cannon MJ, Schmid DS, Hyde TB. Cannon MJ, et al. Rev Med Virol. 2010 Jul;20(4):202-13. doi: 10.1002/rmv.655. Rev Med Virol. 2010. PMID: 20564615 Review. - Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.
Kenneson A, Cannon MJ. Kenneson A, et al. Rev Med Virol. 2007 Jul-Aug;17(4):253-76. doi: 10.1002/rmv.535. Rev Med Virol. 2007. PMID: 17579921 Review.
Cited by
- Verteporfin is an effective inhibitor of HCMV replication.
Lim WY, Lee JH, Choi Y, Yoon K. Lim WY, et al. Virus Res. 2024 Dec;350:199475. doi: 10.1016/j.virusres.2024.199475. Epub 2024 Oct 8. Virus Res. 2024. PMID: 39362410 Free PMC article. - Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.
Logsdon NJ, Eberhardt MK, Allen CE, Barry PA, Walter MR. Logsdon NJ, et al. PLoS One. 2011;6(11):e28127. doi: 10.1371/journal.pone.0028127. Epub 2011 Nov 21. PLoS One. 2011. PMID: 22132227 Free PMC article. - Cytomegalovirus-associated portal vein thrombosis in an immunocompetent patient: an underestimated complication.
Wang T, Kuttikat A, Pulsalkar P, Nanguzgambo A, Bhalara S. Wang T, et al. Oxf Med Case Reports. 2015 May 27;2015(5):294-6. doi: 10.1093/omcr/omv041. eCollection 2015 May. Oxf Med Case Reports. 2015. PMID: 26069839 Free PMC article. - Mapping disparities in viral infection rates using highly multiplexed serology.
Piña A, Elko EA, Caballero R, Metrailer M, Mulrow M, Quan D, Nordstrom L, Altin JA, Ladner JT. Piña A, et al. mSphere. 2024 Sep 25;9(9):e0012724. doi: 10.1128/msphere.00127-24. Epub 2024 Aug 20. mSphere. 2024. PMID: 39162531 Free PMC article. - Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.
Marshall BC, Koch WC. Marshall BC, et al. Paediatr Drugs. 2009;11(5):309-21. doi: 10.2165/11316080-000000000-00000. Paediatr Drugs. 2009. PMID: 19725597 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical